E-DRUG: GPHF-Minilab® Project Transfer to Global Pharma Health Fund e.V.
[It is unfortunate that this important initiative is not independent and with
public funding. Moderator]
Dear Sir or Madame,
with effect from 1st of July 2007, the GPHF-Minilab® project will be operated
by the Global Pharma Health Fund e.V. (GPHF), a charitable organisation
initiated and funded exclusively by donations from Merck, Darmstadt Germany*.
In addition, Merck provides the GPHF with expertise and staff for its local
projects around the world.
The Global Pharma Health Fund succeeds the German Pharma Health Fund e.V.
(GPHF), a pharmaceutical industry initiative that promoted numerous health
projects in developing countries from 1985 to 2007, including the development
and testing of the GPHF-Minilab.
Apart from a new name and sponsorship, there will be no changes whatsoever. All
contact details including email and homepage address will stay the same as
The GPHF-Minilab project will continue to be operated under a non-for-profit
scheme and I will stay your contact for all project related issues on
development, implementation, training and information.
Technologie Transfer Marburg will stay responsible for Minilab assembly,
shipment and invoicing.
The promotion of the new GPHF set-up to appropriate audiences in your
organisation and affiliated institutions, priority disease programmes,
hospitals and other health facilities is much appreciated.
Dr. Jürgen Knackmuss, chairman of GPHF, and I myself are looking forward to
receiving continuous support from existing and new project partners.
Richard W. O. Jähnke
MSc (Pharm), PhD, MBA
Global Pharma Health Fund e.V.
Head Office: Walther-von-Cronberg Platz 6, 60594 Frankfurt, Germany
T: +49-69-962387-600, F: +49-69-962387-609,
Project Office: Rotlintstrasse 75, 60389 Frankfurt, Germany
T: +49-69-46939-662, F: +49-69-46939-852, firstname.lastname@example.org
Chair: Dr. Jürgen Knackmuss
Vice chair: Dr. Walter Huber
The new GPHF is a charitable organisation initiated and sponsored by Merck,
* Merck is a global pharmaceutical and chemical company with sales of EUR 6.3
billion in 2006, a history that began in 1668, and a future shaped by 35,091
employees in 62 countries. Its success is characterized by innovations from
entrepreneurial employees. Merck's operating activities come under the umbrella
of Merck KGaA, in which the Merck family holds an approximately 70% interest
and free shareholders own the remaining approximately 30%. In 1917 the U.S.
subsidiary Merck & Co. was expropriated and has been an independent company